Aldatu Biosciences

Our proprietary genotyping platform technology, PANDAA qDx, overcomes the technical challenges associated with the development of sensitive and accurate diagnostics for complex infectious diseases. PANDAA qDx uniquely enables qPCR - a gold-standard molecular diagnostic technology - for new disease indications like HIV drug resistance. PANDAA qDx testing products will be the first scalable HIVDR testing solutions for emerging markets.